When you hang out a shingle as a full-service healthcare communications company, you must be prepared to offer fully integrated marketing and communications products and services. That translates into some fairly block-and-tackle kinds of offerings, including an ability to provide online and traditional off-line promotional solutions that work synergistically to meet an objective. Also, the agency must be compliance-ready, armed with an up-to-the-minute understanding of FDA promotional guidelines.
When you hang out a shingle as a full-service healthcare communications company, you must be prepared to offer fully integrated marketing and communications products and services. That translates into some fairly block-and-tackle kinds of offerings, including an ability to provide online and traditional off-line promotional solutions that work synergistically to meet an objective. Also, the agency must be compliance-ready, armed with an up-to-the-minute understanding of FDA promotional guidelines.
Another value agencies can be expected to share includes product life-cycle management, including patent expiry strategies. The number of agents facing generic intrusion appears to be at an all-time high. Positioning a brand's point of difference becomes quite challenging when cost containment pressures come into play. No one that I know of has found the magic bullet relative to managing generic intrusion. A practical agency recommendation is to start planning early, not just a year, or a few POAs ahead.
Clients will get a better result from their agency if they share whatever target audience or market information they can. ATU (awareness, trail, and usage) studies are often worth their weight in gold. When clients invest in attitude and usage research, we welcome that input. Although most agencies are used to feeling their way along the mysterious wall that can lead to a viable recommendation, no agency wants to work completely in the dark.
Kane & Finkel Healthcare Communications, an independently owned and operated branding and promotional agency, is located in San Francisco. The agency's capabilities bridge professional and consumer audiences and include online and traditional media.
Telephone: 415-777-4990
E-mail: rfinkel@kaneandfinkle.com
Web site: kaneandfinkle.com
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.